共 50 条
[31]
Bioequivalence of Ertugliflozin/Metformin Fixed-Dose Combination Tablets and Coadministration of Respective Strengths of Individual Components
[J].
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2020, 9 (01)
:50-61
[32]
Determination of metformin in fixed-dose combination tablets by ATR-FTIR spectroscopy
[J].
CHEMICAL DATA COLLECTIONS,
2022, 39
[33]
Fixed-Dose Combination of Canagliflozin and Metformin for the Treatment of Type 2 Diabetes: An Overview
[J].
Advances in Therapy,
2017, 34
:41-59
[37]
Pharmacokinetic Comparison Between a Fixed-Dose Combination of Empagliflozin L-Proline/Metformin and Empagliflozin/Metformin in Healthy Korean Subjects
[J].
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2023, 12 (12)
:1156-1163
[39]
Bioequivalence of Metformin in Ertugliflozin/Metformin Fixed-Dose Combination Tablets to Canadian-Sourced Metformin Coadministered With Ertugliflozin Under Fasted and Fed States
[J].
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2021, 10 (05)
:510-520
[40]
Pharmacokinetics and Safety of a Fixed-Dose Combination of Alogliptin and Extended-Release Metformin Under Fasting and/or Fed Conditions in Healthy Adults
[J].
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT,
2025, 14 (06)
:443-451